Life sciences briefing: Thursday, Sept. 27, 2007
Featured companies: AstraZeneca, Atlantis Components, Cara Therapeutics, CardioMems, Corium International, New Ortho Polymers, Osprey Pharmaceuticals, Othera Pharmaceuticals, StrataGent Life Sciences
Corium acquires Stratagent, raises $25.1M for “transdermal” drugs — Corium International, a Menlo Park, Calif., biotech focused on drugs that can be delivered through the skin, said… Continue Reading
SpectraGenics draws at least $20M for laser hair removal
SpectraGenics, a Pleasanton, Calif., developer of laser hair-removal devices for home use, raised at least $20 million in a fourth round of funding, VentureWire reports (subscription required). The round was led by De Novo Ventures and Technology Partners; other investors included Aphelion Capital, Incubic Venture… Continue Reading
StrataGent closes $16M round for needle-free injections
StrataGent Life Sciences, a San Jose developer of needle-free “microjet” injection systems, said it closed a $16 million second round of financing. The company has so far received $6.65 million of that round; the remainder should become available next year if and when StrataGent meets… Continue Reading